The importance of maintaining FVIII through levels above 1% during prophylactic treatment of hemophilia A: using license study databases to answer key medical questions

P Collins; Jan Astermark; V Blanchette; S Bjorkman; K Fischer; K Casey; P Schroth; S Fritsch; M Oh; G Spotts; B Ewenstein

doi:10.1111/j.1365-2516.2008.01725.x

The importance of maintaining FVIII through levels above 1% during prophylactic treatment of hemophilia A: using license study databases to answer key medical questions

P Collins, Jan Astermark, V Blanchette, S Bjorkman, K Fischer, K Casey, P Schroth, S Fritsch, M Oh, G Spotts, B Ewenstein

Klinisk koagulationsmedicin, Malmö

Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract › Peer review

Originalspråk	engelska
Sidor (från-till)	58-58
Tidskrift	Haemophilia
Volym	14
Nummer	s2
DOI	https://doi.org/10.1111/j.1365-2516.2008.01725.x
Status	Published - 2008
Evenemang	XXVIIIth International Congress of the World Federation of Hemophilia, 2008 - Istanbul, Turkiet Varaktighet: 2008 juni 1 → 2008 juni 5 Konferensnummer: 28

Ämnesklassifikation (UKÄ)

Hematologi

Tillgång till dokument

10.1111/j.1365-2516.2008.01725.x

Citera det här

Collins, P., Astermark, J., Blanchette, V., Bjorkman, S., Fischer, K., Casey, K., Schroth, P., Fritsch, S., Oh, M., Spotts, G., & Ewenstein, B. (2008). The importance of maintaining FVIII through levels above 1% during prophylactic treatment of hemophilia A: using license study databases to answer key medical questions. Haemophilia, 14(s2), 58-58. https://doi.org/10.1111/j.1365-2516.2008.01725.x

@article{7eba6f95d2a849f9b8582e80eb2df22f,

title = "The importance of maintaining FVIII through levels above 1% during prophylactic treatment of hemophilia A: using license study databases to answer key medical questions",

author = "P Collins and Jan Astermark and V Blanchette and S Bjorkman and K Fischer and K Casey and P Schroth and S Fritsch and M Oh and G Spotts and B Ewenstein",

year = "2008",

doi = "10.1111/j.1365-2516.2008.01725.x",

language = "English",

volume = "14",

pages = "58--58",

journal = "Haemophilia",

issn = "1351-8216",

publisher = "Wiley-Blackwell",

number = "s2",

note = "XXVIIIth International Congress of the World Federation of Hemophilia, 2008 ; Conference date: 01-06-2008 Through 05-06-2008",

}

Collins, P, Astermark, J, Blanchette, V, Bjorkman, S, Fischer, K, Casey, K, Schroth, P, Fritsch, S, Oh, M, Spotts, G & Ewenstein, B 2008, 'The importance of maintaining FVIII through levels above 1% during prophylactic treatment of hemophilia A: using license study databases to answer key medical questions', Haemophilia, vol. 14, nr. s2, s. 58-58. https://doi.org/10.1111/j.1365-2516.2008.01725.x

TY - JOUR

T1 - The importance of maintaining FVIII through levels above 1% during prophylactic treatment of hemophilia A: using license study databases to answer key medical questions

AU - Collins, P

AU - Astermark, Jan

AU - Blanchette, V

AU - Bjorkman, S

AU - Fischer, K

AU - Casey, K

AU - Schroth, P

AU - Fritsch, S

AU - Oh, M

AU - Spotts, G

AU - Ewenstein, B

N1 - Conference code: 28

PY - 2008

Y1 - 2008

U2 - 10.1111/j.1365-2516.2008.01725.x

DO - 10.1111/j.1365-2516.2008.01725.x

M3 - Published meeting abstract

SN - 1351-8216

VL - 14

SP - 58

EP - 58

JO - Haemophilia

JF - Haemophilia

IS - s2

T2 - XXVIIIth International Congress of the World Federation of Hemophilia, 2008

Y2 - 1 June 2008 through 5 June 2008

ER -